Ligand validation:3QEL

QEL: 4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol

QEL is a Ligand Of Interest in 3QEL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3QEL_QEL_D_2	61%	7%	0.162	0.95	2.7	2.1	11	10	1	1	100%	1
3QEL_QEL_B_1	49%	8%	0.204	0.951	2.56	2.11	9	8	0	1	100%	1
5EWJ_QEL_B_503	78%	75%	0.135	0.978	0.38	0.59	-	1	2	0	100%	1
7AQI_QEL_A_401	21%	22%	0.191	0.796	1.82	1.43	1	5	2	2	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.